Revenue Recognition (Tables)

6 Months Ended

Jun. 30, 2023

Revenue Recognition

Schedule of disaggregation of revenues by payer types

	Three months ended				Six months ended
	June 30,				June 30,
	2023		2022		2023		2022
(in thousands)
Insurance carriers	$	226,521	$	167,822	$	436,899	$	332,564
Laboratory and other partners		27,449		22,142		50,254		42,879
Patients		7,434		8,236		16,007		16,890
Total revenues	$	261,404	$	198,200	$	503,160	$	392,333

Schedule of total revenue by geographic area

	Three months ended				Six months ended
	June 30,				June 30,
	2023		2022		2023		2022
(in thousands)
United States	$	253,296	$	191,886	$	486,550	$	379,103
Americas, excluding U.S.		1,206		530		2,364		1,271
Europe, Middle East, India, Africa		5,620		3,736		10,816		7,427
Asia Pacific and Other		1,282		2,048		3,430		4,532
Total revenues	$	261,404	$	198,200	$	503,160	$	392,333

Schedule of beginning and ending balances of accounts receivable and deferred revenues

	Balance at		Balance at
	June 30,		December 31,
(in thousands)	2023		2022
Assets:
Accounts receivable, net	$	260,065	$	244,385
Liabilities:
Deferred revenue, current portion	$	15,644	$	10,777
Deferred revenue, long-term portion		21,502		20,001
Total deferred revenues	$	37,146	$	30,778

Schedule of changes in the balance of deferred revenues

	June 30,			June 30,
	2023			2022
(in thousands)
Beginning balance	$	30,778	$	28,722
Increase in deferred revenues		17,402		14,974
Revenue recognized during the period that was included in deferred revenues at the beginning of the period		(7,521)		(5,757)
Revenue recognized from performance obligations satisfied within the same period		(3,513)		(1,209)
Ending balance	$	37,146	$	36,730